| ASSESSMENT OF DIAGNOSTIC PERFORMANCE OF MAGNIFYING ENDOSCOPY AND ENDOSCOPIC ULTRASONOGRAPHY FOR EVALUATION OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA INVASION DEPTH ACCORDING TO NON … Y Sakata, H Nebiki, J Mizusawa, R Kushima, Y Sano, T Hikichi, D Kikuchi, ... Gastrointestinal Endoscopy 99 (6), AB969-AB970, 2024 | | 2024 |
| A multicohort platform trial to improve drug access for pediatric cancer patients in Japan: The PARTNER trial (NCCH2220). B Miyazaki, N Shirakawa, M Sugiyama, A Arakawa, Y Ando, K Anjo, Y Kai, ... Journal of Clinical Oncology 42 (16_suppl), TPS10079-TPS10079, 2024 | | 2024 |
| Adjuvant S-1 vs. observation for resected biliary tract cancer: 5-year follow-up of the JCOG1202/ASCOT. K Nakachi, M Ikeda, M Konishi, J Mizusawa, H Katayama, Y Sano, ... Journal of Clinical Oncology 42 (16_suppl), 4119-4119, 2024 | | 2024 |
| Localized colorectal cancer database integrating 4 randomized controlled trials;(JCOG2310A) K Kataoka, A Ouchi, Y Suwa, H Hirano, T Yamaguchi, Y Takamizawa, ... European Journal of Surgical Oncology 50 (6), 108354, 2024 | | 2024 |
| Statistical Analysis Methods and Reporting of Patient-Reported Outcomes in Randomized Controlled Trials for Cancer Conducted in Japan: A Systematic Review J Mizusawa, G Ogawa, M Terada, H Ishiki, Y Kikawa, N Kiyota Cureus 16 (5), 2024 | | 2024 |
| Prognostic Impact of Post-operative Infectious Complications in Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy: Post Hoc Analysis of a Randomized Controlled Trial … M Hayashi, T Yoshikawa, J Mizusawa, S Hato, Y Iwasaki, M Sasako, ... Journal of Gastrointestinal Cancer, 1-9, 2024 | | 2024 |
| Comparison of proportions and prognostic impact of pathological complete response between evaluations of representative specimen and total specimen in primary breast cancer … T Shien, H Tsuda, K Sasaki, J Mizusawa, F Akiyama, M Kurosumi, ... | | 2024 |
| Transitional dynamics in oncology clinical trials: evaluating the impact of Clinical Trials Act on cooperative groups K Nakamura, K Takeda, AM Saito, M Kato, S Sato, S Nakagawa, ... Japanese Journal of Clinical Oncology, hyae034, 2024 | | 2024 |
| Risk factors for abdominal surgical infectious complications after distal gastrectomy for gastric cancer: A post-hoc analysis of a randomized controlled trial (JCOG0912) Y Taki, S Ito, J Mizusawa, M Yura, Y Sato, T Nomura, M Tsuda, T Omori, ... European Journal of Surgical Oncology 50 (3), 107982, 2024 | | 2024 |
| A multi-institutional randomized phase III study comparing minimally invasive distal pancreatectomy versus open distal pancreatectomy for pancreatic cancer; Japan Clinical … N Ikenaga, T Hashimoto, J Mizusawa, R Kitabayashi, Y Sano, H Fukuda, ... BMC cancer 24 (1), 231, 2024 | | 2024 |
| Protocol digest of a randomized controlled adaptive Phase II/III trial of neoadjuvant chemotherapy for Japanese patients with oesophagogastric junction adenocarcinoma: Japan … R Kita, Y Yanagimoto, H Imazeki, E Booka, T Tsushima, J Mizusawa, ... Japanese Journal of Clinical Oncology 54 (2), 206-211, 2024 | 4 | 2024 |
| Randomized phase II study comparing neoadjuvant FLOT versus DOS for patients with type 4 or large type 3 gastric cancer (JCOG2204). I Nakayama, M Ohashi, J Mizusawa, H Kawachi, T Hashimoto, R Kita, ... Journal of Clinical Oncology 42 (3_suppl), TPS418-TPS418, 2024 | | 2024 |
| Surgeon fatigue in robot-assisted and laparoscopic gastrectomy for gastric cancer: Exploratory prospective observational study ancillary to JCOG1907 randomized controlled trial … K Fujiya, M Terashima, R Kita, J Mizusawa, R Makuuchi, T Omori, ... Journal of Clinical Oncology 42 (3_suppl), TPS422-TPS422, 2024 | | 2024 |
| Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric … M Tokunaga, N Machida, J Mizusawa, S Ito, H Yabusaki, M Hirao, ... Gastric Cancer, 1-10, 2024 | | 2024 |
| Short-term outcomes of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 for gastric cancer with extensive lymph node metastasis (JCOG1704) Y Kurokawa, Y Doki, R Kitabayashi, T Yoshikawa, T Nomura, K Tsuji, ... Gastric Cancer, 1-9, 2024 | 2 | 2024 |
| Clinical impact of skeletal muscle mass change during the neoadjuvant chemotherapy period in patients with gastric cancer: An ancillary study of JCOG1002 R Sato, M Tokunaga, J Mizusawa, Y Sato, S Ito, D Takahari, T Sano, ... World Journal of Surgery 48 (1), 163-174, 2024 | | 2024 |
| 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II … T Yoshikawa, M Terashima, J Mizusawa, S Nunobe, Y Nishida, T Yamada, ... Gastric Cancer 27 (1), 155-163, 2024 | | 2024 |
| A nonrandomized controlled trial: long-term outcomes of LATG/LAPG for cStage I gastric cancer: Japan Clinical Oncology Group Study JCOG1401 C Kunisaki, H Katai, S Sakuramoto, J Mizusawa, H Katayama, S Kadoya, ... Gastric Cancer 27 (1), 164-175, 2024 | 1 | 2024 |
| Association between the antiadhesion membrane and small bowel obstruction after open gastrectomy: A supplemental analysis of the randomized controlled JCOG1001 trial T Toriumi, M Terashima, J Mizusawa, K Uemura, Y Kurokawa, ... Annals of Gastroenterological Surgery 8 (1), 30-39, 2024 | 2 | 2024 |
| Total neoadjuvant therapy followed by a watch-and-wait strategy for patients with rectal cancer (TOWARd): protocol for single-arm phase II/III confirmatory trial (JCOG2010) T Hashimoto, S Tsukamoto, K Murofushi, Y Ito, H Hirano, Y Tsukada, ... BJS open 7 (6), zrad110, 2023 | 2 | 2023 |
